204 related articles for article (PubMed ID: 18780599)
1. Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.
Schmidt H; Pozza SB; Bonfig W; Schwarz HP; Dokoupil K
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):651-5. PubMed ID: 18780599
[TBL] [Abstract][Full Text] [Related]
2. A special, strict, fat-reduced, and carbohydrate-modified diet leads to marked weight reduction even in overweight adolescents with Prader-Willi syndrome (PWS).
Bonfig W; Dokoupil K; Schmidt H
ScientificWorldJournal; 2009 Sep; 9():934-9. PubMed ID: 19768349
[TBL] [Abstract][Full Text] [Related]
3. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
4. Visceral adipose tissue resides within the reference range in children with Prader-Willi syndrome receiving nutritional intervention on a regular basis.
Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
Endocr J; 2020 Oct; 67(10):1029-1037. PubMed ID: 32565499
[TBL] [Abstract][Full Text] [Related]
5. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
6. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
[TBL] [Abstract][Full Text] [Related]
7. Nutritional intervention with hypocaloric diet for weight control in children and adolescents with Prader-Willi Syndrome.
Lima VP; Emerich DR; Mesquita ML; Paternez AC; Carreiro LR; Pina Neto JM; Teixeira MC
Eat Behav; 2016 Apr; 21():189-92. PubMed ID: 26970733
[TBL] [Abstract][Full Text] [Related]
8. Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.
Erhardt É; Molnár D
Nutrients; 2022 May; 14(9):. PubMed ID: 35565916
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study.
Alqahtani AR; Elahmedi MO; Al Qahtani AR; Lee J; Butler MG
Surg Obes Relat Dis; 2016 Jan; 12(1):100-10. PubMed ID: 26431633
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
11. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
[TBL] [Abstract][Full Text] [Related]
12. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous growth in German children and adolescents with genetically confirmed Prader-Willi syndrome.
Hauffa BP; Schlippe G; Roos M; Gillessen-Kaesbach G; Gasser T
Acta Paediatr; 2000 Nov; 89(11):1302-11. PubMed ID: 11106040
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome.
Dağdeviren Çakır A; Baş F; Akın O; Şıklar Z; Özcabı B; Berberoğlu M; Kardelen AD; Bayramoğlu E; Poyrazoğlu Ş; Aydın M; Törel Ergür A; Gökşen D; Bolu S; Aycan Z; Tüysüz B; Ercan O; Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):308-319. PubMed ID: 33565750
[TBL] [Abstract][Full Text] [Related]
15. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
Fillion M; Deal C; Van Vliet G
J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.
Diene G; Angulo M; Hale PM; Jepsen CH; Hofman PL; Hokken-Koelega A; Ramesh C; Turan S; Tauber M
J Clin Endocrinol Metab; 2022 Dec; 108(1):4-12. PubMed ID: 36181471
[TBL] [Abstract][Full Text] [Related]
19. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
20. Specific Dietary Components and Gut Microbiota Composition are Associated with Obesity in Children and Adolescents with Prader-Willi Syndrome.
Garcia-Ribera S; Amat-Bou M; Climent E; Llobet M; Chenoll E; Corripio R; Ibáñez L; Ramon-Krauel M; Lerin C
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
